Adeno-Associated Virus (AAV) has become the vector of choice in many gene therapies. Recent advances in chromatography resin development for viral vectors have demonstrated that AAV purification can be scalable and efficient, achieving high purity and yield in a single step. With an extensively growing pipeline of gene therapy clinical trials it is evident that scalable production solutions are needed. Here we outline the benefits of implementing affinity chromatography in the downstream purification of viral vectors.
Please check the highlighted fields and try again.
Please fill out the information below to request information on the products you selected. If you are already registered, or have requested a quote before, login and this information will be filled out for you.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.
By submitting my personal data to Technology Networks, I acknowledge it will be shared with the Thermo Fisher Scientific group for processing in accordance with the Thermo Fisher Scientific Privacy Policy. I can withdraw my consent and unsubscribe at any time by emailing reply@thermofisher.com.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.